SI1154775T1 - Therapeutic aqueous composition containing a hexahydro-5-pyrimidinamine compound and a polyalkoxylated fatty alcohol - Google Patents

Therapeutic aqueous composition containing a hexahydro-5-pyrimidinamine compound and a polyalkoxylated fatty alcohol

Info

Publication number
SI1154775T1
SI1154775T1 SI200030320T SI200030320T SI1154775T1 SI 1154775 T1 SI1154775 T1 SI 1154775T1 SI 200030320 T SI200030320 T SI 200030320T SI 200030320 T SI200030320 T SI 200030320T SI 1154775 T1 SI1154775 T1 SI 1154775T1
Authority
SI
Slovenia
Prior art keywords
hexahydro
fatty alcohol
aqueous composition
composition containing
polyalkoxylated fatty
Prior art date
Application number
SI200030320T
Other languages
English (en)
Slovenian (sl)
Inventor
Jo(L Cances
Jacques Munerot
Original Assignee
Warner-Lambert Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Company filed Critical Warner-Lambert Company
Publication of SI1154775T1 publication Critical patent/SI1154775T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SI200030320T 1999-02-19 2000-01-22 Therapeutic aqueous composition containing a hexahydro-5-pyrimidinamine compound and a polyalkoxylated fatty alcohol SI1154775T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99400408A EP1029543B1 (en) 1999-02-19 1999-02-19 Therapeutic aqueous composition containing a hexahydro-5-pyrimidinamine compound and a polyalkoxylated fatty alcohol
PCT/EP2000/000487 WO2000048598A1 (en) 1999-02-19 2000-01-22 Therapeutic aqueous composition containing a hexahydro-5-pyrimidinamine compound and a polyalkoxylated fatty alcohol
EP00904948A EP1154775B1 (en) 1999-02-19 2000-01-22 Therapeutic aqueous composition containing a hexahydro-5-pyrimidinamine compound and a polyalkoxylated fatty alcohol

Publications (1)

Publication Number Publication Date
SI1154775T1 true SI1154775T1 (en) 2004-06-30

Family

ID=8241883

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200030320T SI1154775T1 (en) 1999-02-19 2000-01-22 Therapeutic aqueous composition containing a hexahydro-5-pyrimidinamine compound and a polyalkoxylated fatty alcohol

Country Status (10)

Country Link
US (1) US6660743B1 (da)
EP (2) EP1029543B1 (da)
AT (2) ATE227990T1 (da)
AU (1) AU2666000A (da)
DE (2) DE69904014T2 (da)
DK (2) DK1029543T3 (da)
ES (2) ES2188098T3 (da)
PT (2) PT1029543E (da)
SI (1) SI1154775T1 (da)
WO (1) WO2000048598A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9592294B2 (en) 2013-03-20 2017-03-14 Dow Global Technologies Llc Polyalkoxylated alcohols as excipients for pharmaceutical compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4206198A (en) * 1979-05-16 1980-06-03 Basf Wyandotte Corporation Dentifrice
FR2552305B1 (fr) * 1983-09-22 1985-12-20 Salkin Andre Composition a pouvoir bactericide eleve contenant un biguanide et une pyrimidine
US4774078A (en) * 1986-10-06 1988-09-27 Colgate-Palmolive Company Stable antiplaque dentifrice based on hexetidine, zinc ion and fluoride
EP0408174A1 (en) * 1989-07-12 1991-01-16 Warner-Lambert Company Antiseptic composition containing hexahydro-5-pyrimidinamine compounds
CA2074484A1 (en) * 1990-11-26 1992-05-27 Edward J. Carlin Stabilized hexahydro-5-pyrimidinamine compounds in aqueous solution and methods for preparing same

Also Published As

Publication number Publication date
DE69904014T2 (de) 2003-04-30
DK1029543T3 (da) 2003-03-10
AU2666000A (en) 2000-09-04
ATE227990T1 (de) 2002-12-15
DE69904014D1 (de) 2003-01-02
PT1029543E (pt) 2003-04-30
ES2188098T3 (es) 2003-06-16
EP1154775B1 (en) 2003-12-10
PT1154775E (pt) 2004-04-30
US6660743B1 (en) 2003-12-09
DK1154775T3 (da) 2004-04-05
EP1029543A1 (en) 2000-08-23
EP1154775A1 (en) 2001-11-21
ATE255897T1 (de) 2003-12-15
WO2000048598A1 (en) 2000-08-24
EP1029543B1 (en) 2002-11-20
DE60007084T2 (de) 2004-09-30
ES2212983T3 (es) 2004-08-16
DE60007084D1 (de) 2004-01-22

Similar Documents

Publication Publication Date Title
GB9722520D0 (en) Compounds
ATE275342T1 (de) Hochkonzentrierte wässrige glyphosatzusammensetzungen
GEP20104997B (en) Composition comprising anther2 antibodies
ATE303131T1 (de) Zusammensetzungen zur nasalen verabreichung
TR199901077A2 (en) �spen�iyari form�lasyonlar.
BG101540A (en) Interferon conjugates
AU7326801A (en) Compositions containing therapeutically active components having enhanced solubility
DE69308010T2 (de) Sauere wässrige Reinigerzusammensetzungen
AU3597201A (en) Clear aqueous anaesthetic composition
ITMI20001887A0 (it) Ampolla nebulizzatrice per aerosolterapia
GC0000393A (en) Process for the preparation of a highly linear alcohol composition
WO2001010408A3 (de) Wässrige arzneimittelformulierung von moxifloxacin oder salzen davon
HUP0003308A3 (en) Fungicidal combinations comprising phenylacrylic acid derivatives
ZA200107909B (en) Stable aqueous compositions containing a silicon compound.
HK1045945A1 (en) Stable xylometazoline and oxymetazoline solution.
SI1154775T1 (en) Therapeutic aqueous composition containing a hexahydro-5-pyrimidinamine compound and a polyalkoxylated fatty alcohol
IL148725A0 (en) Aqueous pharmaceutical compositions containing circlesonide
GB9906458D0 (en) Compound
AU2002258397A8 (en) Manufacture of thyroid hormone tablets having consistent active moiety amounts
PT1326607E (pt) Composições farmacêuticas contendo ácidos oxapenemo-3- carboxílicos
PT9638T (pt) Electrodo de referencia incorporado no corpo de um cateter mono uso de medicao de ph
TW429144B (en) The pharmaceutical composition comprising the Con.A-Maltose complex and vehicle for oral use
HU0004052D0 (en) Improved process for the preparation of 1-(3'-chloro-2-tertier-butylamino)-propiophenone
KR960014108U (ko) 차체의 사이드용 임팩트와이어
DE486854T1 (de) Waesserige calcitonin-zusammensetzungen zur nasalen verabreichung.